Gaucher disease, the most common lysosomal storage disease, is caused by a deficiency of glucocerebrosidase resulting in the impairment of glucosylceramide degradation. The hallmark of the disease is the presence of the Gaucher cell, a macrophage containing much of the stored glucosylceramide found in tissues, which is believed to cause many of the clinical manifestations of the disease. We have developed adult mice carrying the Gaucher disease L444P point mutation in the glucocerebrosidase (Gba) gene and exhibiting a partial enzyme deficiency. The mutant mice demonstrate multisystem inflammation, including evidence of B cell hyperproliferation, an aspect of the disease found in some patients. However, the mutant mice do not accumulate large amounts of glucosylceramide or exhibit classic Gaucher cells in tissues.
Hiroki Mizukami, Yide Mi, Ryuichi Wada, Mari Kono, Tadashi Yamashita, Yujing Liu, Norbert Werth, Roger Sandhoff, Konrad Sandhoff, Richard L. Proia
Title and authors | Publication | Year |
---|---|---|
A Comparative Biochemical and Pathological Evaluation of Brain Samples from Knock-In Murine Models of Gaucher Disease
Furderer ML, Berhe B, Chen TC, Wincovitch S, Jiang X, Tayebi N, Sidransky E, Han TU |
International journal of molecular sciences | 2024 |
Functional Analysis of Human GBA1 Missense Mutations in Drosophila: Insights into Gaucher Disease Pathogenesis and Phenotypic Consequences
Kuppuramalingam A, Cabasso O, Horowitz M |
Cells | 2024 |
Neuronopathic GBA1L444P Mutation Accelerates Glucosylsphingosine Levels and Formation of Hippocampal Alpha-Synuclein Inclusions
Mahoney-Crane CL, Viswanathan M, Russell D, Curtiss RA, Freire J, Bobba SS, Coyle SD, Kandebo M, Yao L, Wan BL, Hatcher NG, Smith SM, Marcus JN, Volpicelli-Daley LA |
Journal of Neuroscience | 2023 |
Role of neuroinflammation in neurodegeneration development
Zhang W, Xiao D, Mao Q, Xia H |
Signal Transduction and Targeted Therapy | 2023 |
The Complexities of Diagnosis with Co-Existing Gaucher Disease and Hemato-Oncology—A Case Report and Review of the Literature
Sudul P, Piatkowska-Jakubas B, Pawlinski L, Galazka K, Sacha T, Kiec-Wilk B |
Journal of Clinical Medicine | 2023 |
Animal Models for the Study of Gaucher Disease
Cabasso O, Kuppuramalingam A, Lelieveld L, Van der Lienden M, Boot R, Aerts JM, Horowitz M |
International journal of molecular sciences | 2023 |
Inflammation and immune dysfunction in Parkinson disease.
Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V |
Nature reviews. Immunology | 2022 |
Gaucher disease - more than just a rare lipid storage disease.
Roh J, Subramanian S, Weinreb NJ, Kartha RV |
Journal of Molecular Medicine | 2022 |
Role of exosomes in the pathogenesis of inflammation in Parkinson's disease.
Li KL, Huang HY, Ren H, Yang XL |
Neural Regeneration Research | 2022 |
Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.
Arévalo NB, Lamaizon CM, Cavieres VA, Burgos PV, Álvarez AR, Yañez MJ, Zanlungo S |
Frontiers in molecular neuroscience | 2022 |
Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry
Rosenbloom BE, Cappellini MD, Weinreb NJ, Dragosky M, Revel\u2010Vilk S, Batista JL, Sekulic D, Mistry PK |
American Journal of Hematology | 2022 |
Immunogenetic Determinants of Parkinson's Disease Etiology.
Kung PJ, Elsayed I, Reyes-Pérez P, Bandres-Ciga S |
Journal of Parkinson's disease | 2022 |
Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson's Disease.
Kim J, Daadi EW, Oh T, Daadi ES, Daadi MM |
Genes & development | 2022 |
Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers With and Without Parkinson Disease
J Galper, M Balwani, S Fahn, C Waters, L Krohn, Z GanOr, N Dzamko, RN Alcalay |
Movement disorders : official journal of the Movement Disorder Society | 2021 |
C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages
JC Serfecz, A Saadin, CP Santiago, Y Zhang, SM Bentzen, SN Vogel, RA Feldman |
International journal of molecular sciences | 2021 |
Characterization of the visceral and neuronal phenotype of 4L/PS-NA mice modeling Gaucher disease
V Schiffer, E Santiago-Mujika, S Flunkert, S Schmidt, M Farcher, T Loeffler, I Schilcher, M Posch, J Neddens, Y Sun, J Kehr, B Hutter-Paier, I Silman |
PloS one | 2020 |
Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
P Dubot, L Astudillo, N Therville, F Sabourdy, J Stirnemann, T Levade, N Andrieu-Abadie |
Cancers | 2020 |
Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease
Y Buhidma, K Rukavina, KR Chaudhuri, S Duty |
npj Parkinson's Disease | 2020 |
The MicroRNA Centrism in the Orchestration of Neuroinflammation in Neurodegenerative Diseases
N Nuzziello, M Liguori |
Cells | 2019 |
Role of Dysregulated Ion Channels in Sensory Neurons in Chronic Kidney Disease-Associated Pruritus
A Momose, M Yabe, S Chiba, K Kumakawa, Y Shiraiwa, H Mizukami |
Medicines | 2019 |
Recent Developments in LRRK2-Targeted Therapy for Parkinson’s Disease
Y Zhao, N Dzamko |
Drugs | 2019 |
Molecular regulations and therapeutic targets of Gaucher disease
Y Chen, N Sud, A Hettinghouse, C Liu |
Cytokine & Growth Factor Reviews | 2018 |
Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease
M la Mata, D Cotán, M Oropesa-Ávila, M Villanueva-Paz, I Lavera, M Álvarez-Córdoba, R Luzón-Hidalgo, JM Suárez-Rivero, G Tiscornia, JA Sánchez-Alcázar |
Orphanet Journal of Rare Diseases | 2017 |
Intracellular metabolite β-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity
M Nagata, Y Izumi, E Ishikawa, R Kiyotake, R Doi, S Iwai, Z Omahdi, T Yamaji, T Miyamoto, T Bamba, S Yamasaki |
Proceedings of the National Academy of Sciences | 2017 |
Induced Pluripotent Stem Cell Modeling of Gaucher’s Disease: What Have We Learned?
D Santos, G Tiscornia |
International journal of molecular sciences | 2017 |
One Year Follow-Up Risk Assessment in SKH-1 Mice and Wounds Treated with an Argon Plasma Jet
A Schmidt, T Woedtke, J Stenzel, T Lindner, S Polei, B Vollmar, S Bekeschus |
International journal of molecular sciences | 2017 |
Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study
KG Schmidt, MH san Juan, S Trautmann, L Berninger, A Schwiebs, FM Ottenlinger, D Thomas, F Zaucke, JM Pfeilschifter, HH Radeke |
Frontiers in immunology | 2017 |
Glucosylsphingosine Causes Hematological and Visceral Changes in Mice—Evidence for a Pathophysiological Role in Gaucher Disease
J Lukas, C Cozma, F Yang, G Kramp, A Meyer, AM Neßlauer, S Eichler, T Böttcher, M Witt, A Bräuer, P Kropp, A Rolfs |
International journal of molecular sciences | 2017 |
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
YV Taguchi, J Liu, J Ruan, J Pacheco, X Zhang, J Abbasi, J Keutzer, PK Mistry, SS Chandra |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2017 |
Gaucher disease: Progress and ongoing challenges
PK Mistry, G Lopez, R Schiffmann, NW Barton, NJ Weinreb, E Sidransky |
Molecular Genetics and Metabolism | 2017 |
The contribution of mutant GBA to the development of Parkinson disease in Drosophila
G Maor, O Cabasso, O Krivoruk, J Rodriguez, H Steller, D Segal, M Horowitz |
Human Molecular Genetics | 2016 |
Activation of p38 Mitogen-Activated Protein Kinase in Gaucher’s Disease
K Kitatani, M Wada, D Perry, T Usui, Y Sun, LM Obeid, N Yaegashi, GA Grabowski, YA Hannun, R Ahmad |
PloS one | 2015 |
Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages
E Aflaki, N Moaven, DK Borger, G Lopez, W Westbroek, JJ Chae, J Marugan, S Patnaik, E Maniwang, AN Gonzalez, E Sidransky |
Aging Cell | 2015 |
Clinical manifestations and management of Gaucher disease
S Linari |
Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases | 2015 |
Glucocerebrosidase is shaking up the synucleinopathies
M Siebert, E Sidransky, W Westbroek |
Brain | 2014 |
Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease
PK Mistry, J Liu, L Sun, WL Chuang, T Yuen, R Yang, P Lu, K Zhang, J Li, J Keutzer, A Stachnik, A Mennone, JL Boyer, D Jain, RO Brady, MI New, M Zaidi |
Proceedings of the National Academy of Sciences | 2014 |
Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation
S Nair, CS Boddupalli, R Verma, J Liu, R Yang, GM Pastores, PK Mistry, MV Dhodapkar |
Blood | 2014 |
Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation
I Fishbein, YM Kuo, BI Giasson, RL Nussbaum |
Brain | 2014 |
Ubiquitous Transgene Expression of the Glucosylceramide-Synthesizing Enzyme Accelerates Glucosylceramide Accumulation and Storage Cells in a Gaucher Disease Mouse Model
S Barnes, YH Xu, W Zhang, B Liou, KD Setchell, L Bao, GA Grabowski, Y Sun, A Dardis |
PloS one | 2014 |
Dysregulated Sphingolipid Metabolism in Endometriosis
YH Lee, CW Tan, A Venkatratnam, CS Tan, L Cui, SF Loh, L Griffith, SR Tannenbaum, JK Chan |
The Journal of clinical endocrinology and metabolism | 2014 |
The role of inflammation in sporadic and familial Parkinson’s disease
M Deleidi, T Gasser |
Cellular and Molecular Life Sciences | 2013 |
Animal models for metabolic, neuromuscular and ophthalmological rare diseases
G Vaquer, FR Dannerstedt, M Mavris, F Bignami, J Llinares-Garcia, K Westermark, B Sepodes |
Nature Reviews Drug Discovery | 2013 |
Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.
Mistry PK, Taddei T, vom Dahl S, Rosenbloom BE |
Critical Reviews in Oncogenesis | 2013 |
Gaucher disease gene GBA functions in immune regulation
J Liu, S Halene, M Yang, J Iqbal, R Yang, WZ Mehal, WL Chuang, D Jain, T Yuen, L Sun, M Zaidi, PK Mistry |
Proceedings of the National Academy of Sciences | 2012 |
Ceramides as Modulators of Cellular and Whole-body Metabolism
Benjamin T. Bikman, Scott Summers |
Journal of Clinical Investigation | 2011 |
Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders
KJ Valenzano, R Khanna, AC Powe, R Boyd, G Lee, JJ Flanagan, ER Benjamin |
ASSAY and Drug Development Technologies | 2011 |
Animal models for Gaucher disease research
T Farfel-Becker, EB Vitner, AH Futerman |
Disease models & mechanisms | 2011 |
The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β-glucosidase
R Khanna, ER Benjamin, L Pellegrino, A Schilling, BA Rigat, R Soska, H Nafar, BE Ranes, J Feng, Y Lun, AC Powe, DJ Palling, BA Wustman, R Schiffmann, DJ Mahuran, DJ Lockhart, KJ Valenzano |
FEBS Journal | 2010 |
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
PK Mistry, J Liu, M Yang, T Nottoli, J McGrath, D Jain, K Zhang, J Keutzer, WL Chuang, WL Chuang, WZ Mehal, H Zhao, A Lin, S Mane, X Liu, YZ Peng, JH Li, M Agrawal, LL Zhu, HC Blair, LJ Robinson, J Iqbal, L Sun, M Zaidi |
Proceedings of the National Academy of Sciences | 2010 |
Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice
D Vruchte, A Jeans, FM Platt, DJ Sillence |
Journal of Inherited Metabolic Disease | 2010 |
Hyperferritinemia and iron overload in type 1 Gaucher disease
P Stein, H Yu, D Jain, PK Mistry |
American Journal of Hematology | 2010 |
Expanding spectrum of the association between Type 1 Gaucher disease and cancers: A series of patients with up to 3 sequential cancers of multiple types-Correlation with genotype and phenotype
SM Lo, P Stein, S Mullaly, M Bar, D Jain, GM Pastores, PK Mistry |
American Journal of Hematology | 2010 |
Acid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an anti-inflammatory lipid
K Kitatani, K Sheldon, V Anelli, RW Jenkins, Y Sun, GA Grabowski, LM Obeid, YA Hannun |
The Journal of biological chemistry | 2009 |
Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI
A Tessitore, M Pirozzi, A Auricchio |
PathoGenetics | 2009 |
Type II Gaucher disease manifesting as haemophagocytic lymphohistiocytosis
LR Sharpe, P Ancliff, P Amrolia, KC Gilmour, A Vellodi |
Journal of Inherited Metabolic Disease | 2009 |
Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature
M Fost, TA Out, FA de Wilde, EP Tjin, ST Pals, MH van Oers, RG Boot, JF Aerts, M Maas, SV Dahl, CE Hollak |
Annals of Hematology | 2008 |
Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis
DE Sleat, M El-Banna, I Sohar, KH Kim, K Dobrenis, SU Walkley, P Lobel |
Molecular Genetics and Metabolism | 2008 |
Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency
C Settembre, I Annunziata, C Spampanato, D Zarcone, G Cobellis, E Nusco, E Zito, C Tacchetti, MP Cosma, A Ballabio |
Proceedings of the National Academy of Sciences | 2007 |
High incidence of autoantibodies in Fabry disease patients
P Martinez, M Aggio, P Rozenfeld |
Journal of Inherited Metabolic Disease | 2007 |
Upregulation of Proinflammatory Cytokines in the Fetal Brain of the Gaucher Mouse
YB Hong, EY Kim, SC Jung |
Journal of Korean Medical Science | 2006 |
Effective cell and gene therapy in a murine model of Gaucher disease
IB Enquist, E Nilsson, A Ooka, JE Månsson, K Olsson, M Ehinger, RO Brady, J Richter, S Karlsson |
Proceedings of the National Academy of Sciences | 2006 |
Glucosylceramide transfer from lysosomes—the missing link in molecular pathology of glucosylceramidase deficiency: A hypothesis based on existing data
M Elleder |
Journal of Inherited Metabolic Disease | 2006 |
Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology
R Sano, A Tessitore, A Ingrassia, A d'Azzo |
Blood | 2005 |
Possible role of autoantibody in the pathopysiology of GM2 gangliosidoses
Akira Yamaguchi, Kayoko Katsuyama, Kiyotaka Nagahama, Toshiyuki Takai, Ichiro Aoki and Shoji Yamanaka |
Journal of Clinical Investigation | 2004 |
Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease
YH Xu, B Quinn, D Witte, GA Grabowski |
The American Journal of Pathology | 2003 |
Future perspectives for glycolipid research in medicine
RA Dwek, TD Butters, FM Platt, TM Cox, TM Cox |
Philosophical Transactions of The Royal Society B Biological Sciences | 2003 |